Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00589121 · OUTCOME

Regional Failure Rate at Two Years

Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg · Source last updated 2019-06-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
95% Confidence Interval
Time frame
From registration to date of failure (regional progression) or death or last follow-up. Report at time of primary outcome measure analysis.

What was measured

Regional failure is defined as the time from registration to date of failure (regional progression) or death or last follow-up. Two year rate and 95% confidence interval were estimated by the cumulative incidence method.

Analysis population: All eligible patients on Cohort B who started study treatment. (See limitations and caveats, Cohort A is not included.)

Groups in this outcome

Cohort B - No Chemotherapy

Radiation therapy followed by surgery followed by, for patients with positive margins, radiation therapy boost

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Cohort B - No Chemotherapy79

Reported measurements

Source class 1
Values in percentage of participants · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Cohort B - No Chemotherapy0Not reported00Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0
        upper Limit
        0
        value
        0
denoms
  1. counts
    1. group Id
      OG000
      value
      79
    units
    Participants
description
Regional failure is defined as the time from registration to date of failure (regional progression) or death or last follow-up. Two year rate and 95% confidence interval were estimated by the cumulative incidence method.
dispersion Type
95% Confidence Interval
groups
  1. description
    Radiation therapy followed by surgery followed by, for patients with positive margins, radiation therapy boost
    id
    OG000
    title
    Cohort B - No Chemotherapy
param Type
NUMBER
population Description
All eligible patients on Cohort B who started study treatment. (See limitations and caveats, Cohort A is not included.)
reporting Status
POSTED
time Frame
From registration to date of failure (regional progression) or death or last follow-up. Report at time of primary outcome measure analysis.
title
Regional Failure Rate at Two Years
type
SECONDARY
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice